Quantum-Si: AI analysis
$1.15−5.74% today
Quantum-Si sells protein sequencing tools, but losses and dilution dominate
Quantum-Si is a small life sciences tools company trying to build a market around single-molecule protein sequencing. The case here depends on whether its platform can turn technical promise into real, repeatable product demand before cash burn and share dilution do too much damage. At the current price, the market is not paying for a normal valuation story, because free cash flow is still negative and the share count has been climbing fast.
The verdict
Earns little on the money it uses.
Cash flow is too small or negative to judge the price this way.
Debt, swings or a demanding price make losses more likely.
The data cannot tell how protected it is.
Written by AI on Nov 15, 2026 from company filings and prices to Nov 13, 2026.
Read the full analysis
Create a free account to read 3 AI analyses a month: the business, its moat, growth, profits, balance sheet, what the price expects, both cases and what to watch. Pro unlocks every analysis.